Home

MICHAEL S ANDERSON

CIK 1144178 · Chief Executive Officer · last filed 2018-08-14

MICHAEL S ANDERSON is a Chief Executive Officer who has filed 19 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing shows the insider sold $80.0K of AVDL on Aug 14, 2018. Across all open-market trades the lifetime net is +$380.7K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

19

Lifetime Open-Market Net

$380.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Chief Executive Officer 248,953 $21.64 $5.39M $62.9K 8 2018-08-14
AVADEL PHARMACEUTICALS PLC (FLML) Delisted Chief Executive Officer 223,250 — — $317.8K 11 2017-01-03

Recent Filings

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-08-14 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Sell (S) −16,297 -$80.0K EDGAR
2018-06-27 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Buy (P) +2,500 $15.1K EDGAR
2018-05-29 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Buy (P) +3,000 $19.3K EDGAR
2017-12-14 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +25,000 $0 EDGAR
2017-12-11 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Buy (P) +5,000 $44.3K EDGAR
2017-09-14 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Buy (P) +4,000 $39.2K EDGAR
2017-05-22 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Buy (P) +2,500 $25.0K EDGAR
2017-01-13 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +223,250 $0 EDGAR
2017-01-03 AVADEL PHARMACEUTICALS PLC (FLML) Delisted Grant (A) +223,250 $0 EDGAR
2017-01-03 AVADEL PHARMACEUTICALS PLC (FLML) Delisted Disp (D) −223,250 $0 EDGAR
Showing 1–10 of 19
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.